tetradecanoylphorbol acetate has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Cho, S; Hong, B; Si, S; Wang, L; Xu, Y; Yang, Y | 1 |
| Cincotta, AH; Liang, Y; Lubkin, M; Scislowski, PW; Sheng, H | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Hyperlipemia
| Article | Year |
|---|---|
Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzofurans; Biological Transport; CD36 Antigens; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; RNA Interference; Surface Plasmon Resonance; Tetradecanoylphorbol Acetate; Time Factors; Transfection | 2012 |
Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Glucose; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Agonists; Glucokinase; Glucose; Hexokinase; Hyperglycemia; Hyperlipidemias; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; Protein Kinase C; Tetradecanoylphorbol Acetate | 1998 |